Does Zepbound Make You Tired? Fatigue and Tirzepatide

Does Zepbound make you tired? While fatigue is not listed among the most common side effects in FDA prescribing information, some patients report experiencing tiredness during treatment with this weight management medication. Zepbound (tirzepatide) is a once-weekly injectable approved for chronic weight management in adults with obesity or overweight with weight-related conditions. The medication's effects on digestion, metabolism, and appetite may indirectly contribute to feelings of fatigue, particularly during initial treatment or dose increases. Understanding the potential causes and management strategies can help patients navigate this symptom while continuing their weight loss therapy.

We offer compounded medications and Zepbound®. Compounded medications are prepared by licensed pharmacies and are not FDA-approved. References to Wegovy®, Ozempic®, Rybelsus®, Mounjaro®, or Saxenda®, or other GLP-1 brands, are informational only. Compounded and FDA-approved medications are not interchangeable.

Does Zepbound Cause Fatigue or Tiredness?

Zepbound (tirzepatide) is a once-weekly injectable medication approved by the FDA for chronic weight management in adults with obesity or overweight with weight-related comorbidities. According to the FDA prescribing information, fatigue is not listed among the most common adverse reactions, though some patients report experiencing tiredness during treatment.

Tirzepatide works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This mechanism slows gastric emptying, reduces appetite, and improves glycemic control. The medication's effects on digestion and metabolism may indirectly contribute to feelings of fatigue in certain individuals, particularly during the initial weeks of therapy or after dose escalation.

Several factors may explain tiredness in patients taking Zepbound. The gastrointestinal side effects—including nausea, vomiting, diarrhea, and constipation—can lead to reduced food intake, dehydration, and electrolyte imbalances, all of which may manifest as fatigue. Additionally, the caloric deficit associated with weight loss may temporarily affect energy levels as the body adjusts to metabolic changes.

It is important to distinguish between medication-related fatigue and tiredness stemming from other causes, such as inadequate sleep, underlying medical conditions, nutritional deficiencies, or concurrent medications. For patients also taking insulin or sulfonylureas, hypoglycemia (low blood sugar) can present as fatigue and should be monitored. While fatigue is not commonly reported as a direct adverse reaction in clinical trials, the indirect consequences of treatment may contribute to this symptom in some patients.

How Common Is Fatigue with Zepbound?

Fatigue is not prominently listed among the common adverse reactions in the FDA prescribing information for Zepbound. The SURMOUNT clinical trials, which evaluated tirzepatide for weight management, documented the most common side effects as primarily gastrointestinal, including nausea (occurring in up to 43% of participants at the highest dose), diarrhea (up to 30%), vomiting (up to 24%), constipation (up to 24%), dyspepsia, and abdominal pain.

While specific clinical trial data on fatigue with Zepbound is limited, patient experiences suggest that some individuals do experience tiredness while taking the medication. This may be more noticeable during the initial titration phase or following dose increases. The recommended dosing starts at 2.5 mg once weekly for 4 weeks, then increases through 5 mg, 7.5 mg, 10 mg, 12.5 mg, and potentially to 15 mg at 4-week intervals, with symptoms often most pronounced during these transitions.

Indirect contributors to fatigue are more common than direct effects. Gastrointestinal symptoms affect a substantial proportion of patients and can lead to decreased nutritional intake, dehydration, and disrupted sleep patterns—all of which may present as tiredness. Additionally, weight loss itself can temporarily affect energy levels during metabolic adaptation.

Healthcare providers should consider fatigue as a potential symptom when evaluating treatment tolerability, even though it may not be directly attributed to the medication in clinical studies. A comprehensive assessment can help determine whether tiredness is related to Zepbound or has other underlying causes that should be addressed.

Managing Tiredness While Taking Zepbound

If you experience fatigue while taking Zepbound, several practical strategies may help manage this symptom while continuing your weight management therapy. First, ensure adequate hydration, as dehydration from gastrointestinal side effects is a common and modifiable cause of tiredness. Rather than aiming for a fixed amount of water, monitor your hydration status by maintaining pale yellow urine and adjusting fluid intake based on your activity level, climate, and individual needs.

Nutritional adequacy is essential during weight loss treatment. While Zepbound reduces appetite, it remains important to consume balanced meals containing sufficient protein, complex carbohydrates, healthy fats, and micronutrients. Consider working with a registered dietitian to develop a meal plan that meets your nutritional needs within your reduced caloric intake. Small, frequent meals may be better tolerated than larger portions and can help maintain steady energy levels throughout the day.

Key self-management strategies include:

• Prioritize sleep hygiene – Aim for 7-9 hours of quality sleep nightly with consistent sleep and wake times

• Gradual physical activity – Light to moderate exercise can paradoxically improve energy levels, but avoid overexertion during initial treatment phases

• Monitor electrolytes – If experiencing significant gastrointestinal symptoms, consider low or no-sugar electrolyte solutions (especially important if you have diabetes or kidney disease)

• Medication timing – Per the prescribing information, Zepbound can be administered any time of day, with or without meals; some patients prefer evening administration, though there's no proven effect on fatigue

• Dose titration – Follow the prescribed gradual dose escalation schedule to allow your body time to adjust

Avoid making sudden dietary restrictions beyond what occurs naturally from appetite suppression. Additionally, review other medications with your healthcare provider, as some (like diuretics or certain antihypertensives) may compound dehydration risk and contribute to fatigue.

When to Contact Your Doctor About Fatigue

While mild, transient fatigue may be manageable with self-care strategies, certain presentations warrant prompt medical evaluation. Contact your healthcare provider if fatigue is severe, persistent beyond the first few weeks of treatment, or progressively worsening despite adequate hydration and nutrition.

Seek medical attention if fatigue is accompanied by:

• Signs of dehydration – Decreased urination, dark urine, dizziness upon standing, dry mouth, or confusion

• Severe gastrointestinal symptoms – Persistent vomiting preventing fluid intake or severe abdominal pain

• Hypoglycemia symptoms – Shakiness, sweating, confusion, or rapid heartbeat (particularly if taking Zepbound with insulin or sulfonylureas)

• Cardiovascular symptoms – Chest pain, shortness of breath, or rapid heart rate

• Mood changes – New or worsening depression, anxiety, or loss of interest in activities

Call 911 or go to the emergency department immediately for:

• Severe, persistent abdominal pain (especially with back pain or vomiting) which could indicate pancreatitis

• Right upper abdominal pain with fever or yellowing of skin/eyes, which may suggest gallbladder disease

• Facial/tongue swelling or difficulty breathing, which could be signs of a severe allergic reaction

• Severe chest pain or breathing difficulty

• Significant decrease in urine output with swelling, which may indicate kidney problems

Your physician may recommend laboratory investigations to rule out alternative causes of fatigue, including complete blood count (to assess for anemia), comprehensive metabolic panel (to evaluate electrolytes, kidney function, and glucose levels), thyroid function tests, and vitamin B12 or iron studies if indicated. These tests help distinguish medication-related fatigue from other treatable conditions.

In some cases, your doctor may recommend temporarily reducing your Zepbound dose, slowing the titration schedule, or addressing contributing factors. Never discontinue Zepbound without medical guidance, as your provider can help determine whether the benefits of continued treatment outweigh the burden of fatigue or whether alternative weight management strategies should be considered.

Frequently Asked Questions